Also, based on the distinct subcellular localizations of EAAT2 in different BC types (Fig. 3A; e.g., expression at the somata vs expression in the axon terminals), we could imagine that EAAT2 may play different roles in various BCs. Here, SLC1A2 is linked to breast cancer.